Comments
Loading...
Dermata Therapeutics (DRMA) Forecast
NewsEarningsDermata Therapeutics (DRMA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestDermata Therapeutics (NASDAQ:DRMA) Stock Quotes, Forecast and News Summary
Dermata Therapeutics Stock (NASDAQ: DRMA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Dermata Therapeutics (DRMA) stock?
You can purchase shares of Dermata Therapeutics (NASDAQ:DRMA) through any online brokerage.
Who are Dermata Therapeutics (DRMA) competitors?
Other companies in Dermata Therapeutics’s space includes: Entero Therapeutics (NASDAQ:ENTO), Bone Biologics (NASDAQ:BBLG), Qualigen Therapeutics (NASDAQ:QLGN), Anitra (AMEX:AZTR) and Silexion Therapeutics (NASDAQ:SLXN).
What is the forecast, or price target, for Dermata Therapeutics (DRMA) stock?
Dermata Therapeutics has a consensus price target of $6.00.
What is the current price for Dermata Therapeutics (DRMA)?
The stock price for Dermata Therapeutics (NASDAQ: DRMA) is $1.13 last updated January 22, 2025 at 12:45 PM EST.
Does Dermata Therapeutics (DRMA) pay a dividend?
There are no upcoming dividends for Dermata Therapeutics.
When is Dermata Therapeutics (NASDAQ:DRMA) reporting earnings?
Dermata Therapeutics’s Q4 earnings are confirmed for Thursday, March 20, 2025.
Is Dermata Therapeutics (DRMA) going to split?
There is no upcoming split for Dermata Therapeutics.
What sector and industry does Dermata Therapeutics (DRMA) operate in?
Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.